Global RBM requires interoperable architectures across EDC, IRT, eCOA, labs, imaging, EHR, and safety systems, but inconsistent CDISC/HL7 FHIR adoption and proprietary APIs impede near–real-time ...
In a recent video interview with Applied Clinical Trials, Krishna Cheriath, vice president and head of clinical research digital data and AI at Thermo Fish ...
In today's ACT Brief, we explore the leadership priorities that enable meaningful AI gains in clinical research, how Bayesian ...
The White House released its proposed fiscal year 2027 budget Friday, calling for $111.1 billion in discretionary funding for ...
In today's ACT Brief, we examine how real-world data is being applied across oncology, ophthalmology, and other therapeutic ...
In this video interview, Krishna Cheriath, vice president and head of clinical research digital data and AI at Thermo Fisher ...
Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...
In this video interview, Krishna Cheriath, vice president and head of clinical research digital data and AI at Thermo Fisher Scientific, argues that effective patient-centered AI must go beyond direct ...
Long-term follow-up is a necessity for vaccine development, and is critical for establishing safety data, determining how ...
In this video interview, Cheryl Kole, vice president of solution strategy and commercialization at Almac Clinical ...
Kole identified workflow guidance as the most underaddressed gap in current eClinical ecosystems, arguing that technology has ...
In today's ACT Brief, we explore how user-friendly technology reduces errors and site workarounds, strategic approaches to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results